Use of becaplermin gel and Kollagen Medifil particles.
Tomaselli
N L
NL
D000925:Anticoagulants / Q000191:economics / Q000627:therapeutic use*; D000077214:Becaplermin; D024042:Collagen Type I / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D006801:Humans; D015187:Lipectomy / Q000009:adverse effects*; D010982:Platelet-Derived Growth Factor / Q000191:economics / Q000627:therapeutic use*; D020574:Proto-Oncogene Proteins c-sis; D016032:Randomized Controlled Trials as Topic; D013529:Surgical Wound Dehiscence / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome; D014945:Wound Healing / Q000187:drug effects*
D000925:Anticoagulants; D024042:Collagen Type I; D010982:Platelet-Derived Growth Factor; D020574:Proto-Oncogene Proteins c-sis; D000077214:Becaplermin